Amyloid-β and heart failure in Alzheimer’s disease: the new vistas
Frontiers in Medicine,
Journal Year:
2025,
Volume and Issue:
12
Published: Feb. 4, 2025
Alzheimer’s
disease
(AD)
is
the
most
common
cause
of
dementia
and
represents
75%
all
types.
AD
neuropathology
due
to
progressive
deposition
extracellular
amyloid-beta
(A
β
)
peptide
intracellular
hyperphosphorylated
tau
protein.
The
accumulated
Aβ
forms
amyloid
plaques,
while
protein
neurofibrillary
tangles
(NFTs).
Both
plaques
NFTs
are
hallmarks
neuropathology.
fundamental
mechanism
involved
in
pathogenesis
still
elusive,
although
more
conceivable
theory.
Aβ-induced
neurodegeneration
associated
neuroinflammation,
oxidative
stress,
endoplasmic
reticulum
stress
(ER),
mitochondrial
dysfunction
contribute
development
cognitive
impairment
dementia.
Of
note,
not
only
originated
from
brain
but
also
produced
peripherally
and,
via
blood–brain
barrier
(BBB),
can
accumulate
result
AD.
It
has
been
shown
that
cardiometabolic
conditions
such
as
obesity,
type
2
diabetes
(T2D),
heart
failure
(HF)
regarded
possible
risk
factors
for
other
types
dementia,
vascular
HF-induced
chronic
cerebral
hypoperfusion,
inflammation
induce
progression
Interestingly,
a
systemic
causes
which
turn
affects
peripheral
organs,
including
heart.
through
deranged
BBB
be
transported
into
circulation
heart,
leading
HF.
These
findings
suggest
close
relationship
between
However,
exact
AD-induced
HF
fully
elucidated.
Therefore,
this
review
aims
discuss
link
regarding
potential
role
Language: Английский
Decremental response in patients with amyotrophic lateral sclerosis during repetitive nerve stimulation and its relationships with impaired homeostasis
Frontiers in Aging Neuroscience,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 7, 2025
Previous
studies
have
suggested
that
neuromuscular
junction
(NMJ)
denervation
plays
a
critical
role
in
amyotrophic
lateral
sclerosis
(ALS).
Repetitive
nerve
stimulation
(RNS)
has
been
used
as
technique
to
test
transmission,
but
the
sensitivity
and
stability
of
its
parameters
not
investigated
patients
with
ALS.
In
addition,
impact
impaired
homeostasis
on
NMJ
ALS
remains
unclear.
A
total
421
were
enrolled.
Data
their
clinical,
biochemical
electrophysiological
indicators
divided
into
training
set
(collected
from
June
2019
2022)
July
2022
2023).
The
coefficient
variation
(CV)
was
assess
extent
variability.
Stepwise
regression
independent
variable
selection
model
building.
ALS,
area
decrement
had
higher
rate
abnormal
result
lower
CV
than
amplitude
decrement.
No
significant
difference
found
when
first
compound
muscle
action
potential
(CMAP)
compared
either
fourth
or
fifth
one.
Moreover,
multivariate
analysis
suggests
high-density
lipoprotein
cholesterol
(HDL-C)
greatest
decremental
response,
followed
by
serum
uric
acid
(UA)
forced
vital
capacity
(FVC).
Females
larger
range
males.
During
RNS
test,
assessing
significantly
enhances
our
ability
detect
impairment
transmission
Independent
factors
contributing
response
need
be
considered
drug
development
clinical
trials
targeting
Language: Английский
Role of mitogen-activated protein kinase inhibitors in Alzheimer's disease: Rouge of brain kinases
Brain Research Bulletin,
Journal Year:
2025,
Volume and Issue:
224, P. 111296 - 111296
Published: March 10, 2025
Alzheimer's
disease
(AD)
is
the
chief
cause
of
dementia
and
related
mortality
worldwide
due
to
progressive
accumulation
amyloid
peptide
(Aβ)
hyperphosphorylated
tau
protein.
These
neuropathological
changes
lead
cognitive
impairment
memory
dysfunction.
Notably,
most
Food
drug
Administration
(FDA)
approved
anti-AD
medications
such
as
tacrine
donepezil
are
engaged
with
symptomatic
relief
but
do
not
reverse
underlying
AD
neuropathology.
Therefore,
searching
for
new
advisable.
It
has
been
shown
that
inflammatory
signaling
pathways
mitogen-activated
protein
kinases
(MAPK)
intricate
Aβ
neuropathology
in
AD.
In
addition,
inhibition
brain
MAPK
plays
a
critical
role
mitigating
dysfunction
early-onset
Though,
fundamental
mechanisms
beneficial
effects
inhibitors
were
fully
explained.
this
review
aims
discuss
potential
molecular
Language: Английский
The neuroprotective role of Humanin in Alzheimer's disease: The molecular effects
European Journal of Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 177510 - 177510
Published: March 1, 2025
Humanin
(HN)
is
an
endogenous
micropeptide
also
known
as
a
mitochondria-derived
peptide.
It
has
neuroprotective
effect
against
Alzheimer's
disease
(AD)
and
other
neurodegenerative
diseases
by
improving
hippocampal
acetylcholine
attenuating
the
development
of
oxidative
stress
associated
neurotoxicity.
HN
protects
neuron
from
toxic
effects
amyloid
beta
(Aβ).
regarded
biomarker
mitochondrial
stress.
Interestingly,
aging
reduces
brain
expression
HN,
leading
to
cognitive
impairment
elevating
risk
neurodegeneration,
including
AD.
However,
in
old
subjects
AD
patients,
circulating
levels
increase
compensatory
mechanism
reduce
neurodegeneration
dysfunction
Conversely,
studies
demonstrated
reduction
These
findings
indicated
controversial
points
regarding
precise
mechanistic
role
Therefore,
aim
this
review
was
discuss
exact
neuropathology
molecular
mechanisms
Language: Английский
Atorvastatin, simvastatin, rosuvastatin and Amyotrophic lateral sclerosis establishing cause and effect
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 2, 2025
Abstract
Background/Objectives:
Statins
are
drugs
that
lower
lipids
levels,
and
widely
used
to
reduce
the
risk
of
cardiovascular
disease.
Previous
observational
studies
experimental
investigations
have
indicated
statin
is
associated
with
Amyotrophic
Lateral
Sclerosis
(ALS).
However,
causal
relationship
remains
unclear.The
present
study
employs
a
two-sample
Mendelian
randomization
(MR)
analysis
investigate
between
atorvastatin,
simvastatin,
rosuvastatin
ALS
at
nenetic
level.
Methods:
The
utilized
genome-wide
association
(GWAS)
based
on
single-nucleotide
polymorphisms
(SNPs)
for
three
statins
(atorvastatin,
rosuvastatin),
encompassing
data
462,933
participants
obtained
from
UK
Biobank,
80,610
individuals
in
genetic
level
European.
investigation
effects
implemented
five
methods:
inverse
variance
weighting
(IVW),
MR-Egger
regression,
wighted
median,
simple
mode,
weighted
mode.
To
detect
horizontal
pleiotropy,
intercept
test
MR
pleiotropy
residual
sum
outlier
(MR-PRESSO)
global
were
employed.
Instrument
heterogeneity
was
evaluated
by
Cochran’s
Q
statistics.
Sensitivity
performed
via
leave-one-out
method.
Results:
suggest
potential
use
ALS,
odds
ratio
(OR)
confidence
interval
(CI)
providing
further
insight
into
strength
this
association.
results
estimate
revealed
significantly
elevated
atorvastatin
(OR
=
16.93,
95%
CI:
5.42-52.89,
p
1.13E-06),
simvastatin
5.05,
2.92-8.75,
7.49E-09),
6.93E+5,
247.72-1.94E+9,
8.97-05).
sensitivity
highlighted
stability
reliability
casual
results.
Conclusions:
The
provided
evidence
rosuvastatin)
increased
ALS.
Given
drug's
effectiveness
side
effects,
higher
should
be
cautious
about
th
statins.
Further
robust
reserch
needed
confirm
results,
findings
will
provide
valuable
guidance
drug
patients.
Language: Английский
Targeting of AMPK/MTOR signaling in the management of atherosclerosis: Outmost leveraging
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
309, P. 142933 - 142933
Published: April 8, 2025
Language: Английский
Targeting of PP2 A/GSK3β/PTEN Axis in Alzheimer Disease: The Mooting Evidence, Divine, and Devil
Cellular and Molecular Neurobiology,
Journal Year:
2025,
Volume and Issue:
45(1)
Published: April 18, 2025
Abstract
Alzheimer
disease
(AD)
is
a
progressive
neurodegenerative
of
the
brain
due
to
extracellular
accumulation
Aβ.
In
addition,
intracellular
hyperphosphorlyated
tau
protein
which
form
neurofibrillary
tangle
(NFT)
associated
with
neuronal
injury
and
development
AD.
Aβ
NFTs
interact
together
induce
inflammation
oxidative
stress
further
neurodegeneration
in
The
exact
relationship
between
tau,
two
proteins
that
accumulate
within
these
lesions,
has
proven
elusive.
A
growing
body
work
supports
notion
may
directly
or
indirectly
accelerate
formation.
can
adversely
affect
distinct
molecular
cellular
pathways,
thereby
facilitating
phosphorylation,
aggregation,
mislocalization,
accumulation.
drive
pathology
by
activating
specific
kinases,
providing
straightforward
mechanism
enhance
hyperphosphorylation
NFT
Many
signaling
pathways
such
as
phosphatase
2A
(PP2A),
glycogen
synthase
kinase
3β
(GSK3β),
tensin
homologue
(PTEN)
are
intricate
AD
neuropathology.
PP2A
involved
dephosphorylation
deregulated
AD,
correlated
cognitive
impairment.
PTEN
critical
regulator
growth,
survival,
development,
improving
synaptic
plasticity
axonal
regeneration.
Nevertheless,
mutated
impairment
inhibiting
expression
activity
PP2A.
Furthermore,
dysregulation
GSK3β
affects
Aβ,
other
pathogenesis
Therefore,
there
close
interaction
among
GSK3β,
PTEN,
exaggerates
neuropathology
activates
PTEN.
These
findings
specified
related
PP2A,
modulation
single
component
this
axis
not
produce
an
effective
effect
against
Modulation
metformin
statins
reduce
review
aims
discuss
role
GSK3β/PTEN/PP2A
how
targeting
therapeutic
strategy
management
conclusion,
inhibition
activation
be
more
suitable
than
pathway.
Metformin
attenuate
progression
Graphical
Language: Английский
Safety assessment of ezetimibe: real-world adverse event analysis from the FAERS database
Yuchen Han,
No information about this author
Siyuan Cheng,
No information about this author
Jinzheng He
No information about this author
et al.
Expert Opinion on Drug Safety,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 21, 2024
Ezetimibe
is
known
for
its
lipid-lowering
safety
and
tolerability,
but
real-world
adverse
effects
have
not
been
fully
evaluated.
In
this
study,
events
associated
with
ezetimibe
were
investigated
using
the
FAERS
database
period
2004
to
2023.
Language: Английский
Statins for vascular dementia: A hype or hope
Neuroscience,
Journal Year:
2024,
Volume and Issue:
567, P. 45 - 55
Published: Dec. 31, 2024
Language: Английский
Molecular Signaling Pathways of Quercetin in Alzheimer’s Disease: A Promising Arena
Cellular and Molecular Neurobiology,
Journal Year:
2024,
Volume and Issue:
45(1)
Published: Dec. 24, 2024
Abstract
Alzheimer’s
disease
(AD)
is
a
neurodegenerative
characterized
by
cognitive
impairment
and
memory
deficit.
Even
with
extensive
research
studies,
presently,
there
no
effective
treatment
for
the
management
of
AD.
Besides,
most
drugs
used
in
AD
did
not
avert
neuropathology,
still
progressive
status.
For
example,
acetyl
cholinesterase
inhibitors
are
associated
many
adverse
effects,
such
as
insomnia
nightmares.
As
well,
acetylcholinesterase
augment
cholinergic
neurotransmission
leading
to
development
effects
related
high
acetylcholine
level,
salivation,
rhinorrhea,
vomiting,
loss
appetite,
seizure.
Furthermore,
tacrine
has
poor
bioavailability
causes
hepatotoxicity.
These
commonly
do
manage
original
those
reasons,
natural
products
were
repurposed
diseases.
It
been
shown
that
phytochemicals
produce
neuroprotective
against
progression
diseases
different
mechanisms,
including
antioxidant
anti-inflammatory
effects.
Quercetin
(QCN)
reported
exert
an
effect
other
lessening
oxidative
stress.
In
this
review,
electronic
databases
PubMed,
Scopus,
Web
Science
searched
possible
relevant
studies
article
linking
QCN
on
Findings
from
review
highlighted
mechanistic
signaling
pathways
regarding
Nevertheless,
precise
molecular
mechanism
was
completely
clarified.
Consequently,
aims
discuss
Language: Английский